Shares of athenahealth, Inc. (NASDAQ:ATHN) have been assigned an average rating of “Hold” from the twenty-eight analysts that are currently covering the firm, Marketbeat reports. Three equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and thirteen have assigned a buy rating to the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $148.67.

A number of brokerages have recently commented on ATHN. UBS AG set a $123.00 price target on athenahealth and gave the company a “buy” rating in a research note on Monday, May 1st. SunTrust Banks, Inc. reissued a “buy” rating and set a $170.00 price target (up from $150.00) on shares of athenahealth in a research note on Wednesday, August 2nd. Cowen and Company lowered athenahealth from an “outperform” rating to a “market perform” rating and lifted their price target for the company from $127.00 to $133.00 in a research note on Monday, July 31st. ValuEngine raised athenahealth from a “sell” rating to a “hold” rating in a research note on Monday, July 24th. Finally, Leerink Swann set a $140.00 price target on athenahealth and gave the company a “hold” rating in a research note on Friday, May 19th.

ILLEGAL ACTIVITY WARNING: This article was first published by Watch List News and is the sole property of of Watch List News. If you are viewing this article on another site, it was illegally copied and reposted in violation of U.S. & international copyright & trademark laws. The original version of this article can be viewed at https://www.watchlistnews.com/athenahealth-inc-athn-receives-148-67-average-target-price-from-analysts/1516345.html.

In related news, CFO Karl Stubelis sold 3,952 shares of athenahealth stock in a transaction that occurred on Monday, June 5th. The stock was sold at an average price of $138.98, for a total transaction of $549,248.96. Following the transaction, the chief financial officer now owns 21,810 shares of the company’s stock, valued at $3,031,153.80. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Brandon H. Hull sold 800 shares of athenahealth stock in a transaction that occurred on Monday, July 3rd. The shares were sold at an average price of $140.81, for a total value of $112,648.00. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 14,874 shares of company stock worth $2,102,697. 3.20% of the stock is owned by insiders.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Janus Henderson Group PLC bought a new position in shares of athenahealth during the second quarter valued at about $713,856,000. BlackRock Inc. boosted its position in shares of athenahealth by 30,642.6% in the first quarter. BlackRock Inc. now owns 1,599,847 shares of the health services provider’s stock valued at $180,286,000 after buying an additional 1,594,643 shares during the last quarter. Morgan Stanley boosted its position in shares of athenahealth by 9.7% in the first quarter. Morgan Stanley now owns 4,514,305 shares of the health services provider’s stock valued at $508,717,000 after buying an additional 397,837 shares during the last quarter. Elliott Management Corp bought a new position in shares of athenahealth during the second quarter valued at about $52,706,000. Finally, Clearbridge Investments LLC boosted its position in shares of athenahealth by 61.8% in the first quarter. Clearbridge Investments LLC now owns 908,505 shares of the health services provider’s stock valued at $102,379,000 after buying an additional 347,133 shares during the last quarter.

Shares of athenahealth (NASDAQ:ATHN) traded up 1.58% during mid-day trading on Friday, reaching $141.48. The company’s stock had a trading volume of 278,902 shares. athenahealth has a 12 month low of $90.11 and a 12 month high of $158.66. The firm has a market cap of $5.65 billion, a PE ratio of 179.54 and a beta of 1.77. The company has a 50-day moving average of $142.43 and a 200-day moving average of $126.26.

athenahealth (NASDAQ:ATHN) last announced its quarterly earnings results on Thursday, July 20th. The health services provider reported $0.51 EPS for the quarter, beating the Zacks’ consensus estimate of $0.39 by $0.12. athenahealth had a return on equity of 6.91% and a net margin of 2.80%. The firm had revenue of $301.10 million for the quarter, compared to analyst estimates of $298.68 million. During the same period last year, the firm posted $0.34 earnings per share. The business’s revenue for the quarter was up 15.0% on a year-over-year basis. On average, analysts predict that athenahealth will post $1.91 earnings per share for the current year.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.